Surprisingly Low Infertility Rate in Married Type 2 Diabetic Women: A Curious Paradox to the Current Opinion of Insulin Resistance as the Joint Pathogenesis of Polycystic Ovary Syndrome and Type 2 Diabetes Mellitus

August 2015 in “ Diabetes and Metabolic Syndrome: Clinical Research and Reviews ”

Abbas Tavakolian Arjmand, Mannan Nouri, Shima Tavakolian Arjmand

type 2 diabetes mellitus T2DM polycystic ovary syndrome PCOS insulin resistance hyperinsulinemia B-cell competence type 2 diabetes diabetes

TLDR Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

In a study of 265 married women with type 2 diabetes mellitus (T2DM) from a religious community that does not use contraception, researchers found a low infertility rate of 2%, with an average of 5 ± 2.5 pregnancies per woman and a range of 0-15 pregnancies. Only 6 women sought medical advice for delayed pregnancy. The findings challenge the common belief that T2DM and polycystic ovary syndrome (PCOS) are closely related due to shared insulin resistance. The study suggests that T2DM and PCOS may represent different manifestations of insulin resistance, potentially influenced by the level of compensatory hyperinsulinemia and B-cell competence. This indicates that T2DM and PCOS should be considered distinct medical conditions.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research The Prevalence of Polycystic Ovary Syndrome in a Community Sample of Iranian Population: Iranian PCOS Prevalence Study

215 citations, January 2011 in “Reproductive Biology and Endocrinology”

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations, December 2003 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Related Community Posts Join

6 / 1000+ results

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 4 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Detailed 6 months update for FUE HT and 4 years of FIN-MIN journey

in Progress Pictures 194 upvotes 1 year ago

A 25-year-old who has been using minoxidil and finasteride for 4 years to treat hair loss, underwent a successful FUE hair transplant in Mumbai, India, in April 2023. The user reported positive results, including increased hair density and reduced frizziness, and plans to continue treatment for further growth.

community Convinced dad to get into minox 3 months ago and fin 2 months ago

in Is this regrowth? 818 upvotes 5 months ago

A user convinced their 45-year-old dad to use minoxidil and finasteride, resulting in significant hair regrowth. The dad now uses 1mg of finasteride daily and topical minoxidil twice a day, and has also started using 1% ketoconazole shampoo.

community A New Therapeutic Channel to Come Soon: Hair Follicle Sugar Metabolism and Aldose Reductase

in Research/Science 129 upvotes 3 years ago

Hair loss therapies focusing on hair follicle sugar metabolism and aldose reductase. Potential treatments include magnesium supplements, avoiding high glycemic index foods, and antioxidants.

community ‘Long term use of fin/dut may be associated with health risks including fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease and potential kidney disease.’

in Research/Science 22 upvotes 5 months ago

Long-term use of finasteride and dutasteride may be linked to health risks like fatty liver disease, insulin resistance, type 2 diabetes, dry eye disease, and potential kidney disease. Some users believe the risks are low and the medications are generally safe.

community 57% increased chance of pattern hair loss independently associated with the consumption of sugary beverages in men (p<0.001) Pt 2

in Research/Science 479 upvotes 4 months ago

Sugary beverages increase the risk of pattern hair loss in men by 57%. Treatments discussed include Minoxidil, finasteride, and RU58841.

Similar Research

6 / 1000+ results

research Obesity and Polycystic Ovary Syndrome

28 citations, November 2007 in “Medical Clinics of North America”

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

research Compendium of Polycystic Ovarian Syndrome and Its Relevance in Glycation and Diabetes

1 citations, January 2022 in “Journal of experimental and clinical medicine”

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

research Metabolic Risk in PCOS: Phenotype and Adiposity Impact

162 citations, January 2015 in “Trends in Endocrinology and Metabolism”

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Ethnicity, Obesity, and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression

research Ethnicity, Obesity, and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression

189 citations, March 2018 in “Human Reproduction Update”

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

research Hyperandrogenism in Polycystic Ovarian Syndrome and Role of CYP Gene Variants: A Review

49 citations, November 2019 in “Egyptian Journal of Medical Human Genetics”

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

research The Utility of Metformin Therapy in Reproductive-Aged Women with Polycystic Ovary Syndrome

18 citations, March 2014 in “Current Pharmaceutical Biotechnology”

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.